Management of cessation periods after endoscopic hemostasis for patients with non-variceal upper gastrointestinal bleeding taking anti-thrombotic agents : A multi-center pilot study

Management of cessation periods after endoscopic hemostasis for patients with non-variceal upper gastrointestinal bleeding taking anti-thrombotic agents : A multi-center pilot study - Cessation study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030879

Enrollment

Registered

2018-01-22

Start date

2018-01-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-variceal upper gastrointestinal bleeding

Interventions

Endoscopic Hemostasis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Indications for emergency upper gastrointestinal endoscopy included hematemesis, melena, and rapidly progressive anemia.

Exclusion criteria

Exclusion criteria: Patients with variceal bleeding

Design outcomes

Primary

Measure	Time frame
Rebleeding rate after endoscopic hemostasis within one month	—

Countries

Japan

Contacts

Public ContactDaisuke Yamaguchi

National Hospital Organization Ureshino Medical Center Gastroenterology

yamaguchi-sag@umin.ac.jp0954431120

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026